8-K filing — Cronos Group Inc. (CRON)
Filed: 2026-11-05 AccNo: 0001656472-26-000074 Size: 846 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Cronos Group Reports 2026 Third Quarter Financial Results
Cronos Group Inc. announced its 2026 third quarter business results, reporting record net revenue, gross profit, and Adjusted EBITDA for the second consecutive quarter.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Cronos Group CEO Comments on Dutch Cannabis Legalization Requirements
The CEO of Cronos Group stated that full legalization in the Netherlands will require the addition of three or four more cultivation sites.
Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company
Cronos Group has completed its acquisition of CanAdelaar B.V., the largest cannabis company in the Netherlands' adult-use cannabis pilot program (Wietexperiment), for a base purchase price of €57.5 million plus contingent cash earnouts. The acquisition establishes Cronos as the market leader in Europe's largest adult-use cannabis market and enables the company to execute its borderless product strategy in the Netherlands with CanAdelaar's proven operational track record and leading market share.
This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).
Zuanic & Associates Initiates Coverage On Cronos Group with Overweight Rating
Zuanic & Associates analyst Pablo Zuanic initiates coverage on Cronos Group (NASDAQ:CRON) with a Overweight rating.
'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment